Moderna aims to begin early-stage clinical trials of mRNA vaccines targeting 15 priority pathogens that pose a threat to public health by 2025, the company said March 7.
Read the full post on Becker's Hospital Review - Healthcare News
Moderna aims to start vaccine trials for 15 pathogens by 2025
